1
00:00:02,520 --> 00:00:07,440
Speaker 1: Bloomberg Audio Studios, podcasts, radio news.

2
00:00:08,560 --> 00:00:12,440
Speaker 2: The Stock Movers Report, your roundup of companies making moves

3
00:00:12,480 --> 00:00:16,280
Speaker 2: in the stock market, harnessing the power of Bloomberg data.

4
00:00:16,480 --> 00:00:18,240
Speaker 1: Let's take a look at some stocks that are on

5
00:00:18,280 --> 00:00:18,840
Speaker 1: the move today.

6
00:00:18,880 --> 00:00:19,440
Speaker 2: We can do that.

7
00:00:19,880 --> 00:00:21,919
Speaker 1: We're joined by bloombergs Isabel Lee Isbell. What are you

8
00:00:21,920 --> 00:00:24,720
Speaker 1: looking at today? Let's start with CVC Capital Partners. It's

9
00:00:24,760 --> 00:00:27,520
Speaker 1: an Amsterdam listed firm and they agreed to buy Marathon

10
00:00:27,520 --> 00:00:29,800
Speaker 1: Asset Management. So this is a part of their efforts

11
00:00:29,840 --> 00:00:32,479
Speaker 1: to widen their footprint in US credit markets. See A

12
00:00:32,520 --> 00:00:35,160
Speaker 1: group in a note said that the Marathon deal allows

13
00:00:35,159 --> 00:00:37,559
Speaker 1: CVC to fill the white space that is in the

14
00:00:37,680 --> 00:00:40,280
Speaker 1: US credit market and should allow them to really just grow,

15
00:00:40,760 --> 00:00:44,320
Speaker 1: and especially in two areas, which is private wealth and insurance.

16
00:00:44,320 --> 00:00:47,800
Speaker 1: So CBC's a Amsterdam based firm. Ticker CVC it stands

17
00:00:47,880 --> 00:00:51,400
Speaker 1: lightly by one percent, but still it's good news for

18
00:00:51,479 --> 00:00:54,080
Speaker 1: the company. The deal includes earn up consideration linked to

19
00:00:54,080 --> 00:00:57,760
Speaker 1: Marathon's future financial performance over twenty twenty seven to twenty

20
00:00:57,800 --> 00:00:59,320
Speaker 1: twenty nine. I mean most deals have that.

21
00:00:59,520 --> 00:01:00,440
Speaker 2: All right stuff?

22
00:01:00,640 --> 00:01:04,760
Speaker 1: What's next on your list as well? Mankind tickeris MNKD.

23
00:01:04,800 --> 00:01:07,560
Speaker 1: The stock is barely hanging in there, up by four

24
00:01:07,600 --> 00:01:10,319
Speaker 1: tens of one percent. We have the FDA approving and

25
00:01:10,400 --> 00:01:14,160
Speaker 1: updated the company's inhaled insulin, So this was the first

26
00:01:14,160 --> 00:01:15,640
Speaker 1: time I heard that there's such a thing, and it's

27
00:01:15,640 --> 00:01:19,400
Speaker 1: revising recommendations for the starting meal time dosage. The revised

28
00:01:19,400 --> 00:01:22,440
Speaker 1: recommendation are for a FRESA that's the inhaled insulin that

29
00:01:22,560 --> 00:01:27,280
Speaker 1: approved to improve glycemic control and adult patients with diabetes melodists.

30
00:01:27,319 --> 00:01:31,080
Speaker 1: So revisions include recommended those conversions from injected meal time

31
00:01:31,120 --> 00:01:35,119
Speaker 1: insulin or insulin pumps. So that's good news for the stock.

32
00:01:35,280 --> 00:01:37,920
Speaker 1: I feel like with these companies it's always whenever there's

33
00:01:37,959 --> 00:01:41,279
Speaker 1: an FDA approval or any regulatory news, the stock religious spikes.

34
00:01:41,319 --> 00:01:43,000
Speaker 2: Hire would they move they can move.

35
00:01:42,880 --> 00:01:45,440
Speaker 1: Down to yes, I meant remove lawer, Yeah, I mean.

36
00:01:45,319 --> 00:01:47,160
Speaker 2: You've got to be on your toes with those kinds

37
00:01:47,200 --> 00:01:47,520
Speaker 2: of name.

38
00:01:47,640 --> 00:01:51,320
Speaker 1: How about Revolution Medicines, This one is really moving a

39
00:01:51,360 --> 00:01:54,480
Speaker 1: lot lower, down by twenty percent. Tickeris are vmds, So

40
00:01:54,960 --> 00:01:57,560
Speaker 1: they slid after Wall Street Journal reported that Merk and

41
00:01:57,640 --> 00:02:00,000
Speaker 1: the talks to acquire a biotech firm, citing people familar

42
00:02:00,240 --> 00:02:03,200
Speaker 1: with the matter, and this came after the two companies

43
00:02:03,280 --> 00:02:07,120
Speaker 1: couldn't agree on a price, so the deal, if it happened,

44
00:02:07,240 --> 00:02:10,000
Speaker 1: could have valued Revolution Medicines at around thirty billion dollars,

45
00:02:10,040 --> 00:02:13,320
Speaker 1: the report said, adding that talks could restart or maybe

46
00:02:13,360 --> 00:02:16,320
Speaker 1: another suitor could emerge. So mark Is really has been

47
00:02:16,360 --> 00:02:19,120
Speaker 1: looking for deals that will strengthen its treatments to counter

48
00:02:19,520 --> 00:02:23,000
Speaker 1: pit patent losses that erode tales around eighteen billion dollars

49
00:02:23,000 --> 00:02:25,160
Speaker 1: in the next years.

50
00:02:25,760 --> 00:02:29,800
Speaker 2: The Stock Mover's report from Bloomberg Radio. Check back with

51
00:02:29,880 --> 00:02:32,440
Speaker 2: us throughout the day for the latest roundup of companies

52
00:02:32,520 --> 00:02:35,640
Speaker 2: making news on Wall Street and for the latest market

53
00:02:35,639 --> 00:02:40,120
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,

54
00:02:40,200 --> 00:02:43,720
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with

55
00:02:43,800 --> 00:02:45,280
Speaker 2: the Bloomberg Business app.